Back to Journals » OncoTargets and Therapy » Volume 16

MicroRNA 628 Suppresses Migration and Invasion of Breast Cancer Stem Cells through Targeting SOS1 [Retraction]

Authors Lin C, Gao B, Yan X, Lei Z, Chen K, Li Y, Zeng Q, Chen Z, Li H

Received 16 June 2023

Accepted for publication 16 June 2023

Published 19 June 2023 Volume 2023:16 Pages 421—422

DOI https://doi.org/10.2147/OTT.S426266



Lin C, Gao B, Yan X, et al. Onco Targets Ther. 2018;11:5419–5428.

The Editor and Publisher of Onco Targets and Therapy are retracting the published article. Concerns were raised following the authors request to correct an error in Figure 6. It was found that images in Figure 3D and 6C had been duplicated. Specifically,

  • The image for Figure 3D, MCF-7, miR-628 has been duplicated with the image from Figure 6C, MCF-7, miR-628+pcDNA.
  • The image for Figure 6C, MCF-7, miR-628+pcDNA has been duplicated with the image from Figure 6C, MCF-7, miR-628+pcDNA-SOS1.

The authors responded to our follow up queries but were unable to provide a satisfactory explanation for the duplicated images. Additionally, the authors explained they could only provide partial data for their study due to the elapsed time since study completion. As the findings could not be verified the Editor and Publisher made the decision to retract the article and the authors agreed with this.

We have been informed in our decision-making by our editorial policies and the COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


This retraction relates to this paper


Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.